Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Operating Leases (2022 - 2025)

PAVmed (PAVM) has 4 years of Operating Leases data on record, last reported at $2.5 million in Q2 2025.

  • For Q2 2025, Operating Leases changed N/A year-over-year to $2.5 million; the TTM value through Jun 2025 reached $2.5 million, changed N/A, while the annual FY2024 figure was $2.2 million, 50.34% down from the prior year.
  • Operating Leases reached $2.5 million in Q2 2025 per PAVM's latest filing, up from $2.2 million in the prior quarter.
  • Across five years, Operating Leases topped out at $4.5 million in Q4 2023 and bottomed at $1.8 million in Q4 2022.
  • Average Operating Leases over 4 years is $2.9 million, with a median of $2.5 million recorded in 2025.
  • Peak YoY movement for Operating Leases: soared 145.12% in 2023, then tumbled 50.34% in 2024.
  • A 4-year view of Operating Leases shows it stood at $1.8 million in 2022, then surged by 145.12% to $4.5 million in 2023, then crashed by 50.34% to $2.2 million in 2024, then increased by 11.7% to $2.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Operating Leases were $2.5 million in Q2 2025, $2.2 million in Q4 2024, and $2.0 million in Q3 2024.